Yüksel Ürün· @DrYukselUrun · X·· 23 hours agoScore90
Body
VOLGA: OS benefit without adjuvant EV.
Do we really need EV after surgery? An important question for future trials.
Proud to have contributed to this study.
@myESMO @OncoAlert @OpenMedicineHQ #ESMO26 @tompowles1 @Uromigos @urologysummit
357 views · 12 likes · 6 reposts · 0 replies
Conference abstracts
LBA2matched by Presidential Symposium I
Perioperative durvalumab with or without tremelimumab plus neoadjuvant enfortumab vedotin in muscle-invasive bladder cancer: Results from the phase 3 VOLGA trial
https://esmocongress.esmo.orgVOLGA
https://esmocongress.esmo.orgSource: Yüksel Ürün · x.com
